In this study the STS/ACC Transcatheter Valve Therapy registry was used to compare TAVI in nonogenarians versus TAVI in patients 90 years old. Mortality at 30 days and 1-year was significantly higher for nonogenarians (8.8% vs. 5.9%, p
You are here:
Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ACC TVT Registry
Submitted by: Ruben Osnabrugge
Source: J Am Coll Cardiol
Keywords:
Author(s): Mani Arsalan; Molly Szerlip; Sreekanth Vemulapalli; Elizabeth M. Holper; Suzanne V. Arnold; Zhuokai Li; Michael J. DiMaio; John S. Rumsfeld; David L. Brown; Michael J. Mack
